Industry-Sponsored Symposium - Breaking the Cycle: The Role of Microbiota-Based Biotherapies in the Reduction of Recurrent Clostridioides difficile

Paul Feuerstadt, MD, FACG, Sahil Khanna, MBBS, MS, FACG, Caterina M. Oneto, MD

Sponsored by the Academy for Continued Healthcare Learning (ACHL)

This CME activity will inform clinicians about the diagnosis and treatment of recurrent Clostridioides difficile (C. difficile) infections. Faculty will present case-based clinical scenarios to demonstrate the best practices for management of recurrent C. difficile infections, including the emerging role of microbiota restoration therapies in their treatment.

Join the Zoom Meeting using Meeting ID: 825 7243 4577

Open to all ACG 2022 attendees, industry-sponsored symposia provide additional educational opportunities. These programs are independent of the ACG 2022 Annual Scientific Meeting and Postgraduate Course programs. ACG is not the continuing medical education provider of these programs. For more information, see the company sponsor.